指南与共识神经肿瘤

脑膜瘤共识核心临床数据元素(v2021.1)

Consensus core clinical data elements for meningiomas (v2021.1).
指南 / 共识 · Neuro Oncol · 2022-01-01

国际脑膜瘤联盟为统一各中心采集脑膜瘤临床数据、便于将分子改变与临床变量关联,制定脑膜瘤特异性通用数据元素(CDE)。CDE按四阶段流程产生,共定义17项核心CDE(患者级10项、肿瘤级7项)和14项补充CDE(患者级7项、肿瘤级7项),现已公开供采用。

要点

  • 共定义17项核心CDE:患者级10项、肿瘤级7项。
  • 补充CDE共14项:患者级7项、肿瘤级7项。
  • CDE旨在促进数据共享、比较与汇总分析,并欢迎国际反馈以完善。

核心结论

  • CDE为神经肿瘤学界提供讨论框架,促进协作研究的数据共享,并有助于形成用于比较和汇总分析的共同语言。
  • 本文提出的脑膜瘤特异性CDE被定位为随时间演变的动态参数,联盟欢迎国际反馈以进一步细化和实施。

研究设计与样本

  • 国际脑膜瘤联盟制定脑膜瘤特异性核心与补充通用数据元素(CDE)。
  • CDE的产生遵循与 других National Institute of Neurological Disorders and Stroke(NINDS)CDE项目类似的四阶段流程:发现、内部验证、外部验证和分发。

主要发现

  • CDE按患者级和肿瘤级模块组织。
  • 共定义并描述了17项核心CDE(10项患者级、7项肿瘤级)以及14项补充CDE(7项患者级、7项肿瘤级)。
  • 这些CDE现已公开供传播和采用。

关键数值与推荐

  • 核心CDE共17项:患者级10项、肿瘤级7项。
  • 补充CDE共14项:患者级7项、肿瘤级7项。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With increasing molecular analyses of meningiomas, there is a need to harmonize language used to capture clinical data across centers to ensure that molecular alterations are appropriately linked to clinical variables of interest. Here the International Consortium on Meningiomas presents a set of core and supplemental meningioma-specific common data elements (CDEs) to facilitate comparative and pooled analyses. METHODS: The generation of CDEs followed the 4-phase process similar to other National Institute of Neurological Disorders and Stroke (NINDS) CDE projects: discovery, internal validation, external validation, and distribution. RESULTS: The CDEs were organized into patient- and tumor-level modules. In total, 17 core CDEs (10 patient level and 7 tumor level) as well as 14 supplemental CDEs (7 patient level and 7 tumor level) were defined and described. These CDEs are now made publicly available for dissemination and adoption. CONCLUSIONS: CDEs provide a framework for discussion in the neuro-oncology community that will facilitate data-sharing for collaborative research projects and aid in developing a common language for comparative and pooled analyses. The meningioma-specific CDEs presented here are intended to be dynamic parameters that evolve with time and The Consortium welcomes international feedback for further refinement and implementation of these CDEs.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Nassiri F, Wang JZ, Au K, et al. Consensus core clinical data elements for meningiomas (v2021.1). Neuro Oncol. 2022. PMID: 34791428. doi:10.1093/neuonc/noab259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。